Next Article in Journal
Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC
Next Article in Special Issue
Immune Landscape and an RBM38-Associated Immune Prognostic Model with Laboratory Verification in Malignant Melanoma
Previous Article in Journal
Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer
Previous Article in Special Issue
Nuclear Localization of BRAFV600E Is Associated with HMOX-1 Upregulation and Aggressive Behavior of Melanoma Cells
 
 
Article

Article Versions Notes

Cancers 2022, 14(3), 740; https://doi.org/10.3390/cancers14030740
Action Date Notes Link
article xml file uploaded 31 January 2022 11:52 CET Original file -
article xml uploaded. 31 January 2022 11:52 CET Update https://www.mdpi.com/2072-6694/14/3/740/xml
article pdf uploaded. 31 January 2022 11:52 CET Version of Record https://www.mdpi.com/2072-6694/14/3/740/pdf
article supplementary file uploaded. 31 January 2022 11:52 CET - https://www.mdpi.com/2072-6694/14/3/740#supplementary
article html file updated 31 January 2022 11:54 CET Original file -
article html file updated 31 July 2022 08:31 CEST Update https://www.mdpi.com/2072-6694/14/3/740/html
Back to TopTop